Pinto YM - Search Results

1

Angiotensin-(1-7) is a modulator of the human renin-angiotensin system.

Roks AJ, van Geel PP, Pinto YM, Buikema H, Henning RH, de Zeeuw D, van Gilst WH. Roks AJ, et al. Among authors: pinto ym. Hypertension. 1999 Aug;34(2):296-301. doi: 10.1161/01.hyp.34.2.296. Hypertension. 1999. PMID: 10454457

2

Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypotheses.

Pinto YM, Buikema H, van Gilst WH. Pinto YM, et al. Clin Exp Hypertens. 1995 Apr;17(3):441-68. doi: 10.3109/10641969509037418. Clin Exp Hypertens. 1995. PMID: 7613522 Free article. Review.

3

Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology.

Pinto YM, de Smet BG, van Gilst WH, Scholtens E, Monnink S, de Graeff PA, Wesseling H. Pinto YM, et al. Cardiovasc Res. 1993 Nov;27(11):1933-8. doi: 10.1093/cvr/27.11.1933. Cardiovasc Res. 1993. PMID: 8287399

4

The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries.

Buikema H, Pinto YM, Rooks G, Grandjean JG, Schunkert H, van Gilst WH. Buikema H, et al. Among authors: pinto ym. Eur Heart J. 1996 May;17(5):787-94. doi: 10.1093/oxfordjournals.eurheartj.a014947. Eur Heart J. 1996. PMID: 8737111

5

Activated tissue renin-angiotensin systems add to the progression of heart failure.

Pinto YM, Buikema H, van Gilst WH, Lie KI. Pinto YM, et al. Basic Res Cardiol. 1996;91 Suppl 2:85-90. doi: 10.1007/BF00795368. Basic Res Cardiol. 1996. PMID: 8957550 Review.

6

Differential inhibition of plasma versus tissue ACE by utibapril: biochemical and functional evidence for inhibition of vascular ACE activity.

Buikema H, Pinto YM, van Geel PP, Rooks G, de Langen CD, de Graeff PA, van Gilst WH. Buikema H, et al. Among authors: pinto ym. J Cardiovasc Pharmacol. 1997 May;29(5):684-91. doi: 10.1097/00005344-199705000-00018. J Cardiovasc Pharmacol. 1997. PMID: 9213213

7

The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I.

Roks A, Buikema H, Pinto YM, van Gilst WH. Roks A, et al. Among authors: pinto ym. Heart Vessels. 1997;Suppl 12:119-24. Heart Vessels. 1997. PMID: 9476561 Review.

8

Is the A1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease?

van Geel PP, Pinto YM, Buikema H, van Gilst WH. van Geel PP, et al. Among authors: pinto ym. Eur Heart J. 1998 Jul;19 Suppl G:G13-7. Eur Heart J. 1998. PMID: 9717050 Review.

9

Dual pathway for angiotensin II formation in human internal mammary arteries.

Voors AA, Pinto YM, Buikema H, Urata H, Oosterga M, Rooks G, Grandjean JG, Ganten D, van Gilst WH. Voors AA, et al. Among authors: pinto ym. Br J Pharmacol. 1998 Nov;125(5):1028-32. doi: 10.1038/sj.bjp.0702150. Br J Pharmacol. 1998. PMID: 9846641 Free PMC article.

10

Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.

Teisman AC, Pinto YM, Buikema H, Flesch M, Böhm M, Paul M, van Gilst WH. Teisman AC, et al. Among authors: pinto ym. J Hypertens. 1998 Dec;16(12 Pt 1):1759-65. doi: 10.1097/00004872-199816120-00008. J Hypertens. 1998. PMID: 9869009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters